MOPETT
In patients with moderate Pulmonary Embolism (PE), does low dose thrombolysis + anticoagulation, compared with anticoagulation alone, reduce pulmonary artery pressure at 28 months?
Continue reading »A compendium of critical appraisals in Intensive Care Medicine research and related specialties
In patients with moderate Pulmonary Embolism (PE), does low dose thrombolysis + anticoagulation, compared with anticoagulation alone, reduce pulmonary artery pressure at 28 months?
Continue reading »In patients with sub-massive PE, does the use of thrombolysis + heparin, compared to heparin alone, reduce the composite outcome of mortality or clinical deterioration?
Continue reading »In patients with septic shock does a high target mean arterial pressure (MAP), compared to a low target MAP, improve mortality?
Continue reading »In critically ill adults that are expected to be in Intensive Care for 3 days or more, does intensively controlled blood glucose compared to conventionally controlled blood glucose reduce mortality at 90 days?
Continue reading »In adult patients with severe septic shock, does hydrocortisone versus placebo reduce mortality at 28 days?
Continue reading »In patients with suspected acute coronary syndrome does a rapid diagnostic pathway allow early discharge from hospital without more adverse effects when compared with a conventional diagnostic assessment and discharge plan?
Continue reading »Does High Frequency Oscillatory Ventilation (HFOV) improve mortality in patients with new onset moderate-severe ARDS compared with standard ventilation?
Continue reading »In patients with corneal abrasions, is topical tetracaine, compared with saline, for 24 hours a safe and effective analgesic?
Continue reading »Does High Frequency Oscillatory Ventilation (HFOV), compared with conventional ventilation, improve 30 day mortality in patients with ARDS?
Continue reading »In patients with cardiac arrest does adrenaline, compared to placebo, improve survival to hospital discharge?
Continue reading »